NMRA
NMRA

Neumora Therapeutics Inc

NASDAQ · Pharmaceuticals
$2.12
+0.16 (+8.16%)
Analyst Consensus
Buy
14 analysts
Buy 10 71%
Hold 3 21%
Sell 1 7%
Price Target
Analyst Price Target +717.9% upside
Low Target $11.85
Average Target $17.34
High Target $21.76
Current Price $2.12
Current
$2.12
Target
$17.34
$11.85 $17.34 avg $21.76